At AmerisourceBergen, we believe in the promise of biosimilars to deliver cost savings across healthcare. We also understand the potential hurdles these unique products will face. That's why we offer solutions for increasing access to and confidence in these emerging therapies.
Distribution & Commercialization Services
Education & Reimbursement Support
Removing Barriers for Biosimilars
AmerisourceBergen has access to 100% of launched biosimilars in the U.S.
For a complete list of approved biosimilars, refer to FDA biosimilar product information. Commercial launches can take 10-12 months from FDA approval.
Resources & Education
Read the FDA's guidance on biosimilars and get answers to patients' frequently asked questions.